Bracebridge Corporate Finance advised the shareholders of Raleigh Adhesive Coatings Limited, an independent woundcare and bio-diagnostics coatings business, on a £22 million sale to Advanced Medical Solutions Group plc, the AIM listed surgical and advanced woundcare specialist company.
Raleigh was considered non-core by its parent company, Apollo Chemicals. Our role was to advise on the sale of Raleigh in order to maximise value for the shareholders.
We worked alongside the management team at Raleigh for 3 years, developing a business plan, monitoring performance against plan, constructing a comprehensive data room and identifying the most suitable strategic partners.
It was decided that the best fit was with Advanced Medical solutions. We approached AMS and negotiated and structured an off-market deal that represented an excellent outcome for the shareholders.